Literature DB >> 12920436

A novel use for the word "trend" in the clinical trial literature.

Norman A Desbiens1.   

Abstract

BACKGROUND: A new meaning of the word "trend" is appearing in reports of clinical trials.
METHODS: Abstracts of all clinical trials in PubMed with English abstracts that contained the word "trend" for each decade from 1971 to 2001 were reviewed.
RESULTS: "Trend" was used 36 times in 1981, 170 times in 1991, to 375 times in 2001, most often to refer to a judgment about statistical significance. When the expression "significant trend" was accompanied by a P value, the P value was always less than 0.05; when the expression "nonsignificant trend" was accompanied by a P value, all P values were greater than 0.05; 25% of the time, P values were greater than 0.19, and 5% of the time, they were greater than 0.45. When the unmodified word "trend" was accompanied by a P value, most P values were greater than 0.05. However, on 16 occasions, the P value was less than 0.05, and 5% of the time, P values were greater than 0.20; on 1 occasion it was used with a P value of 0.6. About 30% of the time, the exact meaning of the word could not be determined from the abstract.
CONCLUSION: A novel use of the word "trend" has developed in the medical literature over the last several decades. This novel use should be documented in technical dictionaries, and further discussion should occur about the implications of this new connotation. In the meantime, clinical trials reporting can be improved by accompanying the word "trend" with associated P values or point estimates and 95% confidence intervals.

Mesh:

Year:  2003        PMID: 12920436     DOI: 10.1097/00000441-200308000-00002

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  7 in total

1.  Glycerophosphodiester phosphodiesterase domain containing 5 (GDPD5) expression correlates with malignant choline phospholipid metabolite profiles in human breast cancer.

Authors:  Maria D Cao; Mailin Döpkens; Balaji Krishnamachary; Farhad Vesuna; Mayur M Gadiya; Per E Lønning; Zaver M Bhujwalla; Ingrid S Gribbestad; Kristine Glunde
Journal:  NMR Biomed       Date:  2012-01-26       Impact factor: 4.044

2.  Intervertebral discs from spinal nondeformity and deformity patients have different mechanical and matrix properties.

Authors:  Kevin K Cheng; Sigurd H Berven; Serena S Hu; Jeffrey C Lotz
Journal:  Spine J       Date:  2013-11-15       Impact factor: 4.166

3.  Ethics and animal numbers: informal analyses, uncertain sample sizes, inefficient replications, and type I errors.

Authors:  Douglas A Fitts
Journal:  J Am Assoc Lab Anim Sci       Date:  2011-07       Impact factor: 1.232

4.  Delayed exercise promotes remodeling in sub-rupture fatigue damaged tendons.

Authors:  R Bell; M R Boniello; N R Gendron; E L Flatow; N Andarawis-Puri
Journal:  J Orthop Res       Date:  2015-03-31       Impact factor: 3.494

5.  Structured bilaminar coculture outperforms stem cells and disc cells in a simulated degenerate disc environment.

Authors:  Aliza A Allon; Kristin Butcher; Richard A Schneider; Jeffrey C Lotz
Journal:  Spine (Phila Pa 1976)       Date:  2012-05-01       Impact factor: 3.468

6.  Collagen I fiber density increases in lymph node positive breast cancers: pilot study.

Authors:  Samata M Kakkad; Meiyappan Solaiyappan; Pedram Argani; Saraswati Sukumar; Lisa K Jacobs; Dieter Leibfritz; Zaver M Bhujwalla; Kristine Glunde
Journal:  J Biomed Opt       Date:  2012-11       Impact factor: 3.170

7.  Changes in ventricular remodelling and clinical status during the year following a single administration of stromal cell-derived factor-1 non-viral gene therapy in chronic ischaemic heart failure patients: the STOP-HF randomized Phase II trial.

Authors:  Eugene S Chung; Leslie Miller; Amit N Patel; Russell David Anderson; Farrell O Mendelsohn; Jay Traverse; Kevin H Silver; Julia Shin; Gregory Ewald; Mary Jane Farr; Saif Anwaruddin; Francis Plat; Scott J Fisher; Alexander T AuWerter; Joseph M Pastore; Rahul Aras; Marc S Penn
Journal:  Eur Heart J       Date:  2015-06-07       Impact factor: 29.983

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.